Bioqual Other Long-Term Assets 2010-2024 | BIOQ
Bioqual other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Bioqual Annual Other Long-Term Assets
(Millions of US $) |
| 2024 |
$ |
| 2023 |
$ |
| 2022 |
$ |
| 2021 |
$0 |
| 2020 |
$1 |
| 2019 |
$1 |
| 2018 |
$1 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Bioqual Quarterly Other Long-Term Assets
(Millions of US $) |
| 2024-08-31 |
$0 |
| 2024-05-31 |
$0 |
| 2024-02-29 |
$0 |
| 2023-11-30 |
$0 |
| 2023-08-31 |
$0 |
| 2023-05-31 |
|
| 2023-02-28 |
$0 |
| 2022-11-30 |
$0 |
| 2022-08-31 |
$0 |
| 2022-05-31 |
|
| 2022-02-28 |
$0 |
| 2021-11-30 |
$0 |
| 2021-08-31 |
$0 |
| 2021-05-31 |
$0 |
| 2021-02-28 |
$1 |
| 2020-11-30 |
$1 |
| 2020-08-31 |
$1 |
| 2020-05-31 |
$1 |
| 2020-02-29 |
$1 |
| 2019-11-30 |
$1 |
| 2019-08-31 |
|
| 2019-05-31 |
$1 |
| 2019-02-28 |
|
| 2018-11-30 |
|
| 2018-08-31 |
|
| 2018-05-31 |
$1 |
| 2018-02-28 |
|
| 2017-11-30 |
|
| 2017-08-31 |
|
| 2017-05-31 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-02-29 |
|
| 2015-11-30 |
|
| 2015-08-31 |
|
| 2015-05-31 |
|
| 2015-02-28 |
|
| 2014-08-31 |
|
| 2014-05-31 |
|
| 2013-11-30 |
|
| 2013-08-31 |
|
| 2013-05-31 |
|
| 2012-05-31 |
|
| 2012-02-29 |
|
| 2011-11-30 |
|
| 2011-08-31 |
|
| 2011-05-31 |
|
| 2011-02-28 |
|
| 2010-11-30 |
|
| 2010-08-31 |
|
| 2010-05-31 |
|
| 2010-02-28 |
|
| 2009-11-30 |
|
| 2009-08-31 |
|
| 2009-05-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.058B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
